MAPK3 and ovarian carcinoma: Our previous studies have found that mortalin can promote cell proliferation, invasion and metastasis by activating Raf/Mek/Erk1/2 cascade signalling pathway and by regulating cell cycle progression in ovarian cancer cells.11 However, the mechanism of mortalin expression in the tumour cells remained unclear.